Blue Earth Therapeutics Ltd is a clinical stage radiopharmaceutical company dedicated to the advancement of next generation targeted radiotherapeutics to treat patients who have cancer.
With proven leadership and therapeutic radiopharmaceutical expertise, Blue Earth Therapeutics has an emerging pipeline of precision targeted therapeutic radiopharmaceuticals, initially focused on prostate cancer with plans to expand into additional disease areas in oncology.
The Blue Earth Therapeutics story begins in 2021, when the company was formed in Oxford, UK as a sister company to Blue Earth Diagnostics Ltd and part of the Bracco family of companies. Bracco Imaging S.p.A. is a world‐leading diagnostic imaging provider, headquartered in Italy.
The Blue Earth Therapeutics team strongly believes in the potential of targeted therapeutic radiopharmaceuticals and is committed to bringing these innovative technologies to clinicians and patients worldwide.
Company Details
- Employees
- 25
- Founded
- -
- Address
- Magdalen Centre, Oxford Science Park,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Oxford
Blue Earth Therapeutics Questions
Blue Earth Therapeutics's website is https://www.blueearththerapeutics.com/
Blue Earth Therapeutics's LinkedIn profile is https://uk.linkedin.com/company/blue-earth-therapeutics
Blue Earth Therapeutics has
25 employees.
View email and phone details for 25
employees at Blue Earth Therapeutics.
Blue Earth Therapeutics's industry is
Biotechnology Research
Blue Earth Therapeutics's top competitors are
Basecamp Research,
Telix Pharmaceuticals Limited,
Blue Earth Diagnostics,
Evommune,
Blue Earth Diagnostics, Inc. (U.s.),
Alpha-9 Oncology,
Axonis Therapeutics,
Purespring Therapeutics,
Aktis Oncology,
Kivu Bioscience.
Blue Earth Therapeutics's categories are Biotechnology Research
Blue Earth Therapeutics's founding year is 2021
